Unusual 11 Mid-Day Movers 4/9: EPMD, ONCY, SPR, XRM Higher; MNKD, NRGN, NKTR, PTRY Lower - Street Insider

Sign Up | Log In | What is SocialPicks?

Please sign up for SocialPicks site access - it's free!

Unusual 11 Mid-Day Movers 4/9: EPMD, ONCY, SPR, XRM Higher; MNKD, NRGN, NKTR, PTRY Lower
Apr 09, 2008 04:37 PM UTC

Street Insider

Return	Risk
+0.33%	MID

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
STJ	n/a
EPMD	n/a
NKTR	n/a
MNKD	n/a

Via StreetInsider.com News Articles:

EP MedSystems, Inc. (NASDAQ: EPMD) 102% HIGHER; St. Jude Medical, Inc. (NYSE: STJ) will acquire the company for $3.00 per share.

MannKind Corp. (NASDAQ: MNKD) 60.9% LOWER; Warning from Pfizer on inhaled insulin causing lung cancer.

Neurogen Corporation (Nasdaq: NRGN) 31.8% LOWER; today announced it has entered into definitive agreements for a private placement offering of exchangeable preferred stock and warrants with selected institutional investors for gross proceeds of approximately $30.6 million before fees and expenses.

Nektar Therapeutics (NASDAQ: NKTR) 28.4% LOWER; Ceased all negotiations with potential partners for its inhaled insulin programs as a result of

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.